Matches in Wikidata for { <http://www.wikidata.org/entity/Q95362373> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q95362373 description "wetenschappelijk artikel" @default.
- Q95362373 description "наукова стаття" @default.
- Q95362373 name "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 name "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 type Item @default.
- Q95362373 label "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 label "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 prefLabel "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 prefLabel "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 P1433 Q95362373-D072C786-02C6-426A-8DA7-496C6F6B7BD9 @default.
- Q95362373 P1476 Q95362373-019CA079-97D9-4DA3-B9C1-C169E41F9C45 @default.
- Q95362373 P2093 Q95362373-0FE74994-A36F-4A98-A0BC-1C4AF9AB6989 @default.
- Q95362373 P2093 Q95362373-1A0E47E3-CD77-4C19-B491-A1A10AE29DD6 @default.
- Q95362373 P2093 Q95362373-5BB1F44E-BF84-4DF2-AE9F-A7534CB97FD5 @default.
- Q95362373 P2093 Q95362373-755780C2-5BC8-4A82-BCCD-5D0B6078AFC3 @default.
- Q95362373 P2093 Q95362373-7EB36947-F32A-4FCB-A8D5-74F0F89CA676 @default.
- Q95362373 P2093 Q95362373-B6C0741D-983E-456D-A1C1-D1E24BA23772 @default.
- Q95362373 P2093 Q95362373-BC512ABF-1D8A-42F5-8B9F-3BD133F5D2BB @default.
- Q95362373 P2093 Q95362373-D61033A5-4799-4675-9B65-3B1C8B4B0E2B @default.
- Q95362373 P2093 Q95362373-F9106522-379B-4C1D-A198-FFC678175970 @default.
- Q95362373 P2093 Q95362373-FA8BD2BB-8969-459A-8320-FCDD59CAA3E8 @default.
- Q95362373 P304 Q95362373-BE64E174-2418-4F31-A7FE-5E3B8E8DA4F4 @default.
- Q95362373 P31 Q95362373-BF270D95-7A2D-4F18-BEFD-CB44993FC0B4 @default.
- Q95362373 P356 Q95362373-DCB4C0B5-A9A7-4FA7-9B88-68EA90FB6A52 @default.
- Q95362373 P433 Q95362373-DCFC9AC9-4284-46E9-A4FF-64BDF185BED2 @default.
- Q95362373 P478 Q95362373-B40753B5-28A3-41FC-9D62-0024702B2327 @default.
- Q95362373 P50 Q95362373-82124670-9ED6-4BBB-97DC-8098FE37488E @default.
- Q95362373 P50 Q95362373-A0CF4339-56D6-45A3-89AB-31F77438D09F @default.
- Q95362373 P577 Q95362373-D030CF66-5C74-400A-83B6-6DA012122D6B @default.
- Q95362373 P698 Q95362373-055FD409-6F45-4014-9043-903C6230E77A @default.
- Q95362373 P921 Q95362373-8B41A1EB-C476-414D-9A2C-47E61F412B5B @default.
- Q95362373 P356 1078155218816768 @default.
- Q95362373 P698 30514174 @default.
- Q95362373 P1433 Q6295681 @default.
- Q95362373 P1476 "Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemia" @default.
- Q95362373 P2093 "Ako Higashime" @default.
- Q95362373 P2093 "Hironobu Minami" @default.
- Q95362373 P2093 "Hiroshi Matsuoka" @default.
- Q95362373 P2093 "Hiroya Ichikawa" @default.
- Q95362373 P2093 "Junpei Rikitake" @default.
- Q95362373 P2093 "Keiji Kurata" @default.
- Q95362373 P2093 "Kimikazu Yakushijin" @default.
- Q95362373 P2093 "Koji Kawaguchi" @default.
- Q95362373 P2093 "Rina Sakai" @default.
- Q95362373 P2093 "Shigeki Nagao" @default.
- Q95362373 P304 "2010-2015" @default.
- Q95362373 P31 Q13442814 @default.
- Q95362373 P356 "10.1177/1078155218816768" @default.
- Q95362373 P433 "8" @default.
- Q95362373 P478 "25" @default.
- Q95362373 P50 Q49917588 @default.
- Q95362373 P50 Q95362367 @default.
- Q95362373 P577 "2018-12-04T00:00:00Z" @default.
- Q95362373 P698 "30514174" @default.
- Q95362373 P921 Q264118 @default.